Photo from wikipedia
The clinical evaluation of a direct oral anticoagulant (DOAC) treatment for atrial fibrillation (AF) patients with renal dysfunction has not been sufficiently studied. This study aimed to evaluate the safety… Click to show full abstract
The clinical evaluation of a direct oral anticoagulant (DOAC) treatment for atrial fibrillation (AF) patients with renal dysfunction has not been sufficiently studied. This study aimed to evaluate the safety and efficacy of DOACs for patients with a severely impaired renal function.
Keywords:
atrial fibrillation;
renal dysfunction;
safety efficacy;
direct oral
Journal Title: Journal of Arrhythmia
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Arrhythmia
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!